Dexamethasone, a type of corticosteroid, reduced skin thickening, inflammation, and the activity of genes that induce fibrosis (scarring) in a mouse model of systemic sclerosis (SSc), according to a study. The study also demonstrated that dexamethasone reduced the levels of pro-inflammatory molecules produced by certain T-cells derived from SSc…
Using combination therapy for pulmonary arterial hypertension (PAH) improves survival in people with systemic sclerosis (SSc), according to the results of a large study in Australia. The study also demonstrated that the choice between a single medication or a combination of therapies did not vary significantly when comparing participants…
Combining rituximab and mycophenolate mofetil was significantly more effective than using either drug alone at reducing skin thickness and improving lung function after one year in people with systemic sclerosis (SSc), according to a large French study. The safety profile of the combination therapy was similar to that of…
Becoming educated and informed about scleroderma is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your scleroderma journey.
There is no cure for scleroderma yet, but here you can find more information about current therapeutic approaches, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
